ScanGrants - Cardiovascular

Call for Young Leadership: Cardiovascular Research Technologies (CRT) 2014

Call for Young Leadership: Cardiovascular Research Technologies (CRT) 2014

Cardiovascular Research Technologies (CRT) 2014 will take place from February 22 - 25, 2014 in Washington DC. This year’s conference will be the most comprehensive to date. CRT 2014 will have many new and exciting features, including a new, cutting-edge Valve & Structural Heart track, in addition to its standard five subject areas -- Coronary, Endovascular, Research & Innovation, Technology & Renal Denervation and Nurse & Tech.

With over 1600 attendees, CRT continues to be a leading boutique interventional cardiology meeting. Don’t miss this essential conference.

The Young Leadership Recognition Program is designed to feature current and future clinical and academic excellence in physicians practicing interventional cardiology and endovascular medicine.

TOP 25 APPLICANTS WILL RECEIVE:

An invitation to serve as faculty at CRT 2014

Complimentary registration

Three nights stay at the Omni Shoreham Hotel

Coach airfare purchased 28 days in advance by the CRT 2014 Travel Team

A special symposium including current leaders in the field from academia, industry and the FDA will be held at CRT 2014 for the selected Young Leadership Recognition Program participants.

ELIGIBILITY CRITERIA:

Applicants must have completed a formal fellowship program specializing in interventional cardiology, peripheral intervention or their allied fields within the last seven (7) years

Applicants must have published at least five (5) manuscripts in peer reviewed journals related to the field of interventional cardiology (inventions may be included)

Applicants must have presented at least seven (7) presentations in national or international scientific meetings

Applications must also contain the following documents:

Curriculum vitae

Supporting statement from the applicant’s program director verifying that the applicant is an early career investigator as defined in the eligibility criteria

Letters of recommendation from two (2) academic interventional cardiologists

EVALUATION CRITERIA:

Applications will be judged by the CRT 2014 Scientific Committee

SUBMISSION DETAILS: Applications must be submitted electronically. The curriculum vitae, supporting statement from the applicant’s program director, and letters of recommendation from two (2) academic interventional cardiologists should be uploaded electronically with your application.

DEADLINE: Applications must be submitted electronically by November 15, 2013.  Applicants should apply as early as possible before the deadline. All applicants will receive notification of their acceptance status no later than December 2, 2013.

INQUIRIES: If you have any questions, please contact CRTmeeting@gmail.com or call (202) 877-8220.

Call for Fellows: Cardiovascular Research Technologies (CRT) 2014

Call for Fellows: Cardiovascular Research Technologies (CRT) 2014

Cardiovascular Research Technologies (CRT) 2014 will take place from February 22 - 25, 2014 in Washington DC. This year’s conference will be the most comprehensive to date. CRT 2014 will have many new and exciting features, including a new, cutting-edge Valve & Structural Heart track, in addition to its standard five subject areas -- Coronary, Endovascular, Research & Innovation, Technology & Renal Denervation and Nurse & Tech.

With over 1600 attendees, CRT continues to be a leading boutique interventional cardiology meeting. Don’t miss this essential conference.

Selected fellows may have the opportunity to attend CRT 2014 for free! An educational grant has been provided to MedStar Washington Hospital Center to support this wonderful program. This year’s conference will feature the most comprehensive fellows program to date with hands on workshops, simulators, special symposia, and direct access to world-renowned experts in interventional cardiovascular therapy and cardiovascular medicine..

FELLOWSHIP GRANT INCLUDES:

Full CRT 2014 meeting registration fee

Coach train fare or car travel with mileage reimbursement or coach air travel made 28 days in advance with a maximum fare up to $400 (DCA airport preferred)

Up to three nights of hotel accommodations at the Omni Shoreham Hotel

Hotel and Travel arrangements must be made through the CRT 2014 Travel Team. Other forms of transportation, meals outside of course functions, and other miscellaneous expenses are not reimbursable and are the responsibility of the attendee.  

SUBMISSION DETAILS: Applications must be submitted electronically. In order to be eligible for this program all applicants must provide a fellowship verification letter signed by their Program Director or Cath Lab Director on institutional letterhead.  Verification letters must be uploaded with your application. Applications will only be accepted for fellows in the fields of interventional cardiology and radiology, cardiothoracic surgery, vascular surgery, and fellows with a specific interest in endovascular interventions. Third year general cardiology fellows will also be considered for acceptance.

DEADLINE: Applications and verification letters must be submitted by November 15, 2013.  Once the complimentary registration quota is filled, registration is available on a paid basis. All applicants will receive notification of their acceptance status no later than December 1, 2013.

INQUIRIES: If you have any questions, please contact CRT.Fellows@gmail.com or call Ashley Johnson at (202) 877- 8206.

Roche Translational & Clinical Research Center Request for Proposals for Young Investigator Award

Roche Translational & Clinical Research Center Request for Proposals for Young Investigator Award

Roche is pleased to announce that we are accepting applications for the 2013 TCRC Young Investigators Award.  The awards are intended to provide support for the earlier stages of scientific research career development, so they are to be awarded to the employing institutions of promising emerging researchers.  Proposals will be evaluated based on scientific merit and innovation of the projects proposed to be conducted using the awards. Four awards will be presented on Oct 1, 2013 during the scientific symposium inaugurating Roche’s Translational and Clinical Research Center in New York City.  Researchers performing investigations (clinical, in vitro/in vivo or informatics) focused on disease understanding of the following disease areas are encouraged to apply:

Cardiovascular & Metabolism – Diabetes and related complications

Neuroscience - Spinal Muscular Atrophy

Virology - Influenza

Oncology - Treatment and diagnosis of Acute Myeloid Leukemia (AML).

Program Overview and Eligibility:  Eligibility is limited to researchers performing investigations (clinical, in vitro/in vivo or informatics) in the foregoing disease areas who have completed their graduate degrees (MD and or Ph.D) within the past 5 years.  Four awards of Fifty Thousand ($50,000 USD) Dollars  will be granted to the employing institutions of each selected researcher in North America to be used , towards extending fellowship training, funding for new project, or as supplemental funding for ongoing projects. 

Application Process:

All applications will be reviewed and selected by an internal TCRC committee comprised of Discovery & Translational Medicine experts. All awards must comply with TCRC policies and processes. TCRC, in its sole discretion, reserves the right to modify the terms of any proposal, eligibility, program, award, policy and process at any time for any reason.

Submission deadline:  August 30th, 2013

E-mail your submissions to nicole.nieves@roche.com.  Please attach the following:

1. One page summary of  research project

2. Curriculum Vitae

Timelines:

1. August 30th – Submissions deadline

2. September 16th – Notification to recipients

3. October 1st – Award presentation

4. 4th Quarter 2014 – Research update required

Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension

Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension

This Program supports innovative scientific research that will advance knowledge in the field of pulmonary arterial hypertension. The awards provide financial support to 3 junior faculty researchers for a 2-year period. Each award is funded up to $130,000, to be paid in annual installments of up to $65,000 per year for 2 years.

The awards provide financial support to 3 junior faculty researchers for a 2-year period. Each award is funded up to $130,000, to be paid in annual instalments of up to $65,000 per year for 2 years.

For a complete overview of the Program, please go to:

http://researchscholars.gilead.com/PAH

The deadline for online application submission is Midnight, Eastern Daylight Time, Friday, August 2, 2013.

The Committee and Gilead Sciences, Inc., recognize the importance and value of basic and clinical research in the field of pulmonary arterial hypertension. We look forward to working with you to encourage and promote the submission of excellent research proposals for consideration of support through these awards.

If you have any questions, please contact the Research Scholars Program Coordinator at:

Telephone: + 1 646-674-1820

E-mail: pahresearchscholars@contacthmc.com

Paul M. Hassoun, MD, Committee Chair
Professor of Medicine
Director, Pulmonary Hypertension Program
Johns Hopkins University
Baltimore, MD


 

Society for Vascular Surgery Multicenter Clinical Studies Planning Grant

Society for Vascular Surgery Multicenter Clinical Studies Planning Grant

Application Deadline:

Letter of Intent:  October 1, 2013

Full application, if invited:  February 1, 2014

The SVS Foundation announces a funding opportunity directed to Society for Vascular Surgery (SVS) members developing grant applications for high-impact multicenter clinical studies in the treatment and/or prevention of vascular diseases.

The SVS Foundation Multicenter Clinical Studies Planning Grant is one component of a broad strategy to facilitate clinical research directed at solving high-impact questions in the care of patients with vascular diseases. SVS recognizes that members face significant gaps in knowledge in their day to day care of patients with vascular disease and acknowledges the challenge of designing and executing clinical studies to provide concrete clinical guidance. Prospective multi-center studies are particularly challenging; yet these studies may be the only practical approach to recruit the large numbers of patients required to achieve statistical power to provide practicing surgeons clear guidance. A major hurdle for investigators preparing grant applications for multicenter studies are the costs of developing compelling preliminary data, recruiting and training collaborators, and creating tools in support of a competitive proposal.

The purpose of the Planning Grant is to help investigators complete competitive applications for external funding (e.g. NIH) of full-scale prospective multicenter clinical studies. The Planning Grant is broadly modeled after R34 awards from the National Institutes of Health (NIH Clinical Trial Planning Grant Program and NHLBI Clinical Trial Pilot Studies). These programs permit early peer review of the rationale and experimental design of a proposed Phase III or IV clinical trial and support development of a research team, assessment tools, and oversight necessary in a competitive application. Support might also be used to obtain critical preliminary data important for the design of a larger study. Examples include: defining the appropriate study population and feasibility of recruitment; demonstrating the feasibility of an intervention or an outcome measure; estimating sample size, effect size, attrition or response rates; or developing and piloting survey instruments. Funds might also be used to prepare an investigator’s brochure or procedure manual, or to recruit and train collaborating centers and trial oversight.  Proposals for phase I trials will not be considered responsive to this mechanism.

The Planning Grant specifically targets SVS member investigators with a track-record of productive clinical research. Applications addressing “high impact” areas in the management of patients with vascular disease will be considered most responsive. For example, SVS has recently identified a number of clinical research priorities:

SVS Clinical Research Priorities

Further investigate the optimal management of asymptomatic carotid stenosis

Compare effectiveness of medical versus invasive therapy (open or endovascular) for claudication

Compare effectiveness of initial open versus endovascular infra-inguinal revascularization for critical limb ischemia

Develop and compare effectiveness of clinical strategies to reduce cardiovascular and other perioperative complications (e.g. wound) following vascular intervention

Determine the effectiveness of strategies to enhance arteriovenous fistula maturation and durability

Develop best practices for management of chronic venous ulcer

Further investigate the optimal adjunctive medical therapy to enhance the success of lower extremity intervention

Identify and evaluate medical therapy to prevent abdominal aortic aneurysm growth

Evaluate ultrasound versus computed tomography angiography surveillance post- endovascular aneurysm repair

The Planning Grant application must describe the full-scale study that it is intended to support in sufficient detail to establish its significance and potential clinical impact and to define the need for this award. The full-scale clinical study application must be fairly well developed, so that a targeted investment could be expected to significantly strengthen the research plan and facilitate grant preparation and submission.  Planning Grant funding will be for no more than one year and up to $100,000 USD (direct costs only) and is expected to culminate in the submission of an application for external funding of a multi-center clinical study within six months of its completion, or the first possible grant cycle from the targeted funding agency, if more than six months later. Applications proposing activities that cannot be completed with this level and duration of funding will not be considered responsive.

Principal Investigator (PI) Eligibility Requirements

PI must hold an MD or equivalent degree with postgraduate clinical training in vascular surgery

PI must be an SVS Active Member

PI must have demonstrated experience in the conduct of clinical research

Individuals with active extramural research support are eligible, provided there is limited scientific or budgetary overlap

Financial Support and Award Period

Awards will be for up to $100,000 USD (direct costs only) for a period up to one year.

Contact Information

For questions, email Sarah Murphy​; phone 800-258-7188; fax 312-334-2320

2013 American Association for Thoracic Surgery Resident Critical Care Scholarship

2013 American Association for Thoracic Surgery Resident Critical Care Scholarship

The Resident Critical Care Scholarship provides an opportunity to expose cardiothoracic surgery residents to cardiovascular critical care by providing assistance to attend the Cardiovascular Thoracic (CVT) Critical Care Conference taking place October 10-12, 2013 at the Omni Shoreham Hotel in Washington, D.C. All ACGME accredited cardiothoracic surgical training programs in the United States and RCPSC accredited cardiothoracic surgical residency programs in Canada will have an opportunity to expose one CT Surgery resident to what will be an important aspect of their training.

Funded by the AATS Graham Research Foundation and administered by the Association, the 2013 AATS Resident Critical Care Scholarship will provide a stipend of $500 to the resident's institution to help offset the cost of travel and hotel accommodations. The AATS Graham Research Foundation will also provide complimentary registration to the course. If necessary, the respective training program will supplement any additional resident travel and accommodation costs.

To be eligible for this scholarship, residents must be enrolled in an ACGME-accredited cardiothoracic surgical training program in the United States or RCPSC-accredited residency program located in Canada. Each Program Director is provided an opportunity to select one CT surgery resident for this scholarship. Up to 75 recipients will be awarded on a first come first served basis. Award recipients must agree to submit a summary survey to the Association within thirty days after the completion of the course.

Deadline: August 30th, 2013

To request a Program Director's Committment Form please contact the AATS administrative office at admin@aats.org

Call for Nominations: Douglas P. Zipes Distinguished Young Scientist Award

Call for Nominations: Douglas P. Zipes Distinguished Young Scientist Award

Established in 2005, the Douglas P. Zipes Distinguished Young Scientist Award recognizes young scientists who have made outstanding contributions to the field of cardiovascular disease and who have amassed an impressive body of scientific research in either the basic or clinical domains.

Offered annually, the program differs from other ACC distinguished awards in the following areas:

Nominations will be invited from both the membership and from the wider national/international community;

The recipient will need not necessarily be an ACC member at the time of nomination; and

The awardee may not be widely known.

The recipient must be no more than five years out of training from an accredited U.S. institution or comparable international training program.

One awardee will be selected each year. The award recipient will be invited to present his or her scientific work at the ACC Annual Scientific Sessions. He or she will also be recognized at the Annual Convocation Ceremony and receive a monetary prize of $1,000. Travel, housing and registration expenses to attend the Scientific Sessions will also be provided.

Nominations are invited from the following:

U.S. and international cardiovascular organizations, and

U.S. and international medical schools and/or cardiology departments.

To submit a nomination, the following must be received by July 15, 2013:

A nominating letter submitted on letterhead summarizing the curriculum vitae, highlighting those accomplishments that are relevant to the award;

No more than three supporting letters submitted on letterhead;

Nominee’s curriculum vitae;

Nominee’s list of top 10 (ten) publications; and

Description of nominee’s research interests and professional experience relevant to the award.

The nomination packet, including letters, curriculum vitae and other materials, may be sent by email to Kristin Robertson at kroberts@acc.org.

Call for Nominations: Heart Failure Society of America Nursing Leadership Award

Call for Nominations: Heart Failure Society of America Nursing Leadership Award

Deadline for submission: Monday, July 1, 2013

Notification to award winner: July 29, 2013

Individual selected to receive an award will receive $1,000 and complimentary registration to the 2013 HFSA Annual Scientific Meeting. The award will be presented at the 2013 HFSA Annual Scientific Meeting.

Eligibility

Candidates must be:

A registered nurse who works directly with heart failure patients and their families.

Must be an HFSA member continuously since January 2011.

HFSA Nursing Committee members and past winners are not eligible; however previous applicants can reapply (new application is required). Individuals cannot apply for more than one nursing award in the same year.

Nomination Process: Candidate can either self-nominate or be nominated by a colleague.

Council on Cardiovascular Disease in the Young Visiting Professor for Career Development Award

Council on Cardiovascular Disease in the Young Visiting Professor for Career Development Award

Application Deadline June 15, 2013

The American Heart Association’s Council on Cardiovascular Disease in the Young (CVDY) is proud to sponsor
the CVDY Visiting Professor for Career Development Award. This award serves to foster the academic development of fellows and/or junior faculty in pediatric cardiology and cardiac surgery by providing support
for a program to sponsor a Visiting Professor who will provide education, mentorship, and career guidance to
physicians early in their academic career.

The Visiting Professor should have a commitment to and history of successful mentoring of fellows and junior faculty. The Visiting Professor may have expertise in areas of pediatric cardiovascular medicine not available at the host institution. In addition, the Visiting Professor may subsequently be invited to join the Scholarship Oversight Committee for a fellow or junior faculty member of the host institution thereby extending the mentoring goal of the program.

Who Should Apply

Pediatric cardiology or cardiac surgery programs in the United States with or without training fellowships are eligible to apply. The chief‐of‐service must be a member of the American Heart Association with a CVDY council affiliation (either primary or secondary). The Visiting Professor may be from the United States or abroad and should be nationally or internationally known in the field of pediatric cardiovascular medicine.

-- A Visiting Professor may receive only one award per year.

-- An institution may receive only one award per year and may not receive the award in consecutive
years.

Awards Given

Two awards are available per year. The award provides an honorarium of $1,000 to the Visiting Professor and
up to $1,500 for travel and other expenses. The duration of the program should be two days. Academic development is an essential component of the visit and the major focus of this award. The program should include didactic sessions in the Visiting Professor’s subspecialty area, clinical discussions and rounds relevant to the Visiting Professor’s expertise, review of ongoing research projects at the host institution, mentoring sessions (individual and/or group) with the fellows and junior faculty, and opportunities for informal interactions between the Visiting Professor, fellows and junior faculty. Meetings between the fellows and junior faculty members with the Visiting Professor should be focused toward developing productive academic careers. Participation from fellows and/or junior faculty from institutions in the surrounding geographic area is encouraged.

How to Apply

Grant recipients are chosen by the CVDY Early Career & Mentoring Committees through a careful peer review
process.

The application must include:

1. Curriculum vitae of the host Division Chief and the Visiting Professor.

2. A letter signed by the proposed Visiting Professor affirming acceptance of the invitation.

3. Two‐to four‐page statement (not more than 1000 words) by the host institution addressing the
following points:

a. How does the program fulfill the specific needs, aims, and goals for career development at the host institution?

b. What expertise does the Visiting Professor provide that would enhance the host institution’s mission of early career development?

c. Proposed agenda

d. Specify the people who will be exposed to the Visiting Professor. Please include approximate number of fellows and junior faculty who will participate in the mentoring sessions, including possible participants from outside the host institution.

e. How will the host institution publicize the program within and outside the institution?

4. Visiting Professor must be a Council Member of the Council on Cardiovascular Disease in the Young. If you need to become an AHA/ASA Professional Member, you should do so no later than four business days prior to the award deadline to allow processing. Your membership number is required on the application.

Important Dates

-- Deadline for applications is June 15, 2013

-- Host institution and Visiting Professor are announced at the Annual CVDY Dinner at AHA Scientific Sessions

Applications and any questions should be directed to:

Dena Thomas
Manager, Council on Cardiovascular Disease in the Young (CVDY)
American Heart Association
Email: dena.thomas@heart.org
Phone: (214) 706‐1476

ISCTR-American College of Cardiology Foundation Cardiovascular Translational Research Scholarship

ISCTR-American College of Cardiology Foundation Cardiovascular Translational Research Scholarship

sponsored by Dignity Health, St. John's Hospital

The purpose of the program is to recognize and provide financial support for research efforts by outstanding cardiovascular scholars. This scholarship is to encourage junior faculty in the early phases of their careers in the field of cardiology. The program is intended for a physician with a strong interest in developing a career in cardiovascular translational research.

One year of previous interventional cardiology training is required. The duration of the program is one year. The awardee will develop skills and expertise in translating basic biological and device concepts into clinical application.

Goal: The overall goal of the program is to provide the clinical scientist (a physician) with the necessary scientific background that does not exist in today's curriculum. The program will enable the awardee to expedite scientific discovery to clinical application, ultimately benefitting the patient and society by providing science earlier and decreasing the developmental costs related to new devices and/or novel biologic therapies.

The program will cover the topics of:

• Basic science

• Preclinical science

• Clinical science and trial design

• Regulatory pathways (FDA) for IND (investigational new drug application) and IDE (investigational new device exemption)

The emphasis will be on biologics (stem cell therapy and genomics) and cardiovascular device development.

Objectives: The fellow will:

• Develop the skills and knowledge to take a scientific concept to the bedside

• Gain substantial knowledge about the steps in cardiovascular translational research

• Understand product development related to devices or biologics 

• Learn about toxicology studies required on small and large animal models that serve for IND or IDE application 

• Understand the statistical design and analysis required for toxicology studies, and phase I, II, and III clinical trials 

• Learn about the regulatory pathways for and how to prepare an IND (Investigational Drug Application) and an IDE (Investigational Device Exemption)

• Understand fundraising, NIH grant application process, opportunities in the venture capital arena, and developing and maintaining relationships with industry

Eligibility: Applicants eligible for the award are those who:

• Have completed one year of previous interventional cardiology. 

• Are members or are eligible to become a member of the ACC and ISCTR

• Will spend the duration of the Scholarship at an institution that has the ability to perform translational research (conducts both preclinical and clinical research) and can administer the curriculum found here:

http://www.cardiosource.org/~/media/Files/ACC/Membership/awards/ISCTR%20Curriculum.ashx

The Award: The award will offer $60,000 of salary support to begin July 1, 2014 and run through June 30, 2015.

Funding Source: The ACCF is grateful to Dignity Health St. John’s Hospital for their financial support for this award.

Nomination Procedure: Criteria for selection includes qualifications, background, interests, and commitment of the applicant.

How to Apply: The submission site for applications will open this summer. Please stay tuned for more information.

Deadline: September 23, 2013

For more information: Email Julia Berman or call 800-253-4636, ext. 6648.

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease

Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training.

Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, hypertension, heart failure, hyperlipidemia, inflammatory mechanisms and new pathways for drug discovery. Proposals focusing on clinically relevant outcomes as a result of the metabolic syndrome, diabetes or obesity are also encouraged. Outcomes studies should focus on clinical/and or systems of care (e.g., quality improvement) interventions, and use outcomes measures of importance to both patients and society, including mortality, significant morbidity or quality of life changes, or economic effects.

Preference for one award will be given to applicants focusing on disparities of care.  Despite increased attention to health disparities at the national, state and community levels, relatively little progress has been made in achieving the vision of eliminating racial and ethnic health disparities.  Since the rates of cardiovascular mortality in the United States are significantly higher for these patients and this is, in fact, the leading cause of death in this demographic, innovative approaches to eliminating these disparities are critical.  In an effort to encourage and support research in this area, proposals will be encouraged that focus on gender, race, geographic, and economic inequalities in cardiovascular care.

Eligibility: Anyone currently in an adult cardiology fellowship training program recognized by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association and who has the recommendation and agreement of his/her training program director and institution.

Selection: Judging will be by the ACCF/Research Fellowship Awards Committee. Criteria for selection will include:

• Scientific quality of the project;

• Relevance to the research focus as described above;

• Qualifications and commitment of the applicant; and

• The quality of the training environment.

Successful applicants may pursue this protected year of research either within or following their three years of required training. Preference will be given to individuals who:

• Will pursue clinical research training and experience directly involving patients or human subjects.

• Have had no more than two years of prior full-time research experience either in clinical or basic research.

• Will not hold another major external fellowship or salary award, (e.g., from the National Institutes of Health or the American Heart Association) during the ACCF/Merck funded year.

The Award: Four fellowships in the amount of $70,000 each, to be used for salary support, for one year of research to begin July 1, 2014 and run through June 30, 2015.

Funding Source: The ACCF is grateful to the Merck Company Foundation for their continued financial support for these awards.

Deadline: September 23, 2013

For more information: Email Julia Berman or call 800-253-4636, ext. 6648.

American College of Cardiology Foundation/William F. Keating, Esq. Endowment Career Development Award

American College of Cardiology Foundation/William F. Keating, Esq. Endowment Career Development Award

The purpose of the award is to recognize and provide financial support for research efforts by outstanding your cardiovascular scholars. This award is to encourage junior faculty in the early phases of their careers in the field of cardiology. The award will provide one junior faculty member with a year of research support. Preference will be given to applications focusing on hypertension and/or peripheral vascular disease.

Eligibility: Applicants eligible for the award are those who:

1. Will hold rank of instructor or assistant professor at the time of the initiation of the award and have completed adult, pediatric, surgical cardiology fellowship training in a program approved by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association;

2. Are members or are eligible to become a member of the American College of Cardiology (ACC);

3. Are no more than five years out of training;

4. Have the recommendation and agreement of their division chiefs and their chiefs' assurance that the awards' support will provide protected time for the applicants to pursue their research programs; and

5. Have an agreement with their institutions that the full amount of the award will be designated for the salary support.
The Award: The award will offer $70,000 salary support for one year of research to begin July 1, 2014 and run through June 30, 2015.

Funding Source: The ACC is grateful to the William F. Keating Endowment Fund for supporting this award.

Nomination Procedure: Criteria for selection includes scientific quality of the project, qualifications and commitment of the applicant, and support of the environment to foster the proposed project and applicant's success. Preference will be given to applications focusing on hypertension and/or peripheral vascular disease

Application Deadline: September 23, 2013

For more information: Email Julia Berman or call 800-253-4636, ext. 6648.

American College of Cardiology Foundation Young Investigator Awards Competition

American College of Cardiology Foundation Young Investigator Awards Competition

The Young Investigator Awards competition encourages and recognizes young scientific investigators of promise, upon whom progress in the field of cardiology is dependent. A manuscript and abstract summarizing any problem that relates to cardiovascular disease whether it be in etiology, pathophysiology, diagnosis, or therapy.

Award Categories include the following:

1. ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology

2. Physiology, Pharmacology and Pathology

3. Clinical Investigations, Congenital Heart Disease and Cardiac Surgery

4.Cardiovascular Health Outcomes and Population Genetics

*Doctorate level nurses, physician assistants and clinical pharmacists in research are strongly encouraged to apply in this category

Eligibility: Physicians, scientists, medical students, and other healthcare providers currently in residency or fellowship programs, or are no more than three years out of training. PhD, PharmD or DNP candidates who are no more than three years out of training may also apply.    

Note: Candidates will be eligible for this award up to four years after completion of training if more than three months of family or sick leave was taken during training or in the first three years after completion of training.

The Award: The first place winner for each category receives $2,000, second place winners receive $1,000; three honorable mentions in each category receive $500. Travel, hotel and meals up to $1,500 will be reimbursed for all 20 finalists to attend the YIA Competition at ACC.14 in Washington, DC.

Funding Source: Support for the ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology is provided by a grant from CV Path Institute and the family of Herman K. Gold.

Deadline: October 11, 2013

For more information: Email Kristin Robertson or call 800-253-4636, ext. 6390.

Summer 2013 - Mentored Clinical and Population Research Award

Summer 2013 - Mentored Clinical and Population Research Award

Application deadline: July 18, 2013

Award Activation Date:  Jan. 1, 2014

Applications must be received no later than 5:00 p.m. CDT on the deadline date.  The system will shut down at 5:00 p.m. CDT.  Early submission is encouraged.  Your institutional Grants Officer (GO) has the final responsibility of submitting your completed application to the American Heart Association.  It is important that you check with your GO for his/her internal deadline.

Objective

To encourage early career investigators who have appropriate and supportive mentoring relationships to engage in high quality introductory and pilot clinical studies that will guide future strategies for reducing cardiovascular disease and stroke while fostering new research in clinical and translational science, and encouraging community- and population-based activities.

This grant does not fund basic science or support senior researchers, but encourages mentoring of early career investigators.

Science Focus

Funding is available for research related to cardiovascular disease and stroke prevention or treatment, or to related clinical and public health problems, including multidisciplinary efforts.  Proposals are encouraged on provider behavior, patient behavior, behavioral outcomes, risk factor outcomes, disease outcomes, cost benefit analyses, efforts to evaluate outcomes of patient care delivery and patient/provider and/or system compliance and adherence to recommendations, as well as pilot clinical research studies that may provide preliminary data for larger-scale investigation. Studies using existing databases are also encouraged.  Ancillary studies or a clearly defined sub-study of an ongoing clinical research study are also encouraged. There must, however, be clear justification that the proposal is a sub-study and not a piece of an already funded project.

Target Audience

• Healthcare professional with a masters or post-baccalaureate doctoral degree, including M.P.H., R.N., Pharm.D., M.D., D.O. or Ph.D. 

• Interdisciplinary research teams are eligible.

Individuals are not eligible to be the principal investigator if they hold or have held:

• Certain NIH awards (such as RO1, R21, PO1)

• Certain AHA awards (BGIA, SDG, EIA, GIA); or

• An award equivalent to any of the above (an independent investigator award)

Citizenship

At the time of application, must have one of the following designations:

• U.S. citizen

• Permanent resident

• Pending permanent resident.  Applicant must have applied for permanent residency and have filed form I-485 with the U.S. Citizenship and Immigration Services and have received authorization to legally remain in the U.S. (having filed an Application for Employment form I-765)

• E-3 Visa - specialty occupation worker

• H1-B Visa - temporary worker in a specialty occupation

• F-1 - Student Visa - temporary worker in a specialty occupation

• J-1 Visa - exchange visitor

• O-1 Visa - temporary worker with extraordinary abilities in the sciences

• TN Visa - NAFTA Professional

• G-4 Visa - family member of employee of international organizations and NATO

Awardee must meet American Heart Association citizenship criteria throughout the duration of the award.

Applicants are not required to reside in the United States for any period before applying for American Heart Association funding.

Sponsor

All applicants must  identify a sponsor with an earned doctorate and a track record of high quality clinical investigation.

Annual Budget - National

Salary/Fringe:   Up to $35,000 per year for salary and fringe of the principal investigator, collaborating investigator(s), and other participants with faculty appointments, including an allowance of up to $5,000 for the sponsor.

Institution may supplement stipend.

Indirect:  10 percent ($7,000)

Project Support:  Project-related expenses, such as salaries of technical personnel, consultative services, supplies, equipment, computer/electronics, travel, volunteer subject costs, publication costs, within the following limits:

• Travel - $3,000 per year; international travel must have prior AHA approval.

• Computer purchase - National allows $5,000 for computer equipment/electronics. 

Maximum Annual Award Amount:  $77,000

Award Duration:  Two years

Total Award Amount:  $154,000

Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award

Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award

Submission Deadline: August 1, 2013

This award recognizes clinical and academic excellence in interventional vascular medicine and aims to stimulate continued commitment and dedication to both outstanding patient care and ongoing academic inquiry by young investigators. The winner will be announced and the award of a $10,000 scholarship will be presented in the Main Arena at TCT 2013.

Candidates for this award must be within five years of the start of their first fellowship or training period and specializing in interventional vascular medicine (interventional cardiology, endovascular medicine, or structural heart disease). Depending on the length of training, physicians in practice for one or two years may be eligible. Candidates may be from any country.

The Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award is sponsored by the Cardiovascular Research Foundation.

Criteria and Specifications

• Curriculum vitae

• One or more manuscripts (published, in press, or not yet submitted) that the applicant first-authored or one or more abstracts that the applicant first-authored, accompanied by:

◦ A three to five (3-5) page description of the project(s) and results

◦ At least one supporting letter from a project leader or mentor describing the importance of the project(s) and the applicant's role

• Two letters of recommendation from supervisors who have directly witnessed the applicant in the patient care setting attesting to clinical excellence

Deadline and Submission

All materials must be received on or before August 1, 2013. Materials received after August 1, 2013, will not be considered.

If you have any questions, please contact Denise Tong at 646-434-4501 or dtong@crf.org

Lesbian Health Fund Research Grant Program

Lesbian Health Fund Research Grant Program

Application Receipt Deadlines: May 15 and October 15

The Lesbian Health Fund (LHF), a program of GLMA: Health Professionals Advancing LGBT Equality, was established in 1992 to define, study, and educate lesbians and their health care providers about lesbian health issues. LHF's mission is to improve the health of lesbians, other sexual minority women (SMW) and their families through research.

Research areas include:

Understanding social, family, and interpersonal influences as sources of stress or support

Eliminating inequalities in health care, including barriers to care, and improving quality of care and utilization rates

Development and testing of interventions to address mental and physical health needs of lesbians and other SMW, including but not limited to depression, identity related issues, eating disorders, substance abuse, obesity, cancer risks, cardiovascular disease and sexually transmitted infections

Sexual and reproductive health, including family & parenting issues

The deadlines for receipt of applications are May 15 and October 15.

Applications will be evaluated using the following 100 point scale:

Research design - 35 Points

Feasibility of accomplishing the project - 20 Points

Investigators' qualifications - 15 Points

Significance of the project to the lesbian community - 15 Points

Probability for Significat Future Funding - 15 points

In general, investigators are notified by mail approximately two months from the application deadline of its approval for funding. Grants range from $500 to $10,000. Grant award checks will be made to the primary institution identified on the application cover page. You may not begin your proposed research until you have received funding from LHF. Grant money is NOT awarded for completed research or for projects in progress.

Interim and final reports are to be submitted by the principal investigator. Upon completion of the project the investigator will be expected to present the results at either the annual Women in Medicine conference or the Annual Conference of GLMA. Within six months of project completion, the investigator is expected to submit a manuscript to a peer-reviewed journal for publication. A copy of the manuscript is to be sent simultaneously to the LHF Program Manager.

Grant Application Format

1. Cover Page

2. Abstract of the Project in 500 words or less (This should be a word document.)

3. Detailed Plan of Project:

maximum of six double spaced typed pages

includes hypotheses, goals and specific objectives of the project, a brief discussion of relevant background information, the relationship of the proposed project to other work already accomplished in the field, methods, sample size calculation with power analysis, and the significance of the project to the lesbian community

4. Itemized Budget:

supplies and expenses with justification (budget $750 for presentation at a conference)

support from other resources for this project for this fiscal year

total amount requested for the project from Lesbian Health Fund. The Lesbian Health Fund does not cover personnel costs (salary and benefits) for the Investigators or indirect institution costs.

5. Study protocol as approved or submitted to the Institutional Review Board of the investigator's institution if animals or humans are involved in the project

6. Curriculum Vitae of Principal Investigator (PI), Co-Investigator, and Faculty Supervisor if the PI is a student, and of any other project member mentioned by name in the application. If a faculty supervisor is involved, submit letter of support from that faculty member for supervising the project. Current LHF grantees may not participate in a new grant as PI or Co-Investigator until LHF receives their written Final Report.

7. Signed statement by the Investigator and, if applicable, by the Co-Investigator that:

all publications resulting from the research conducted from the award will acknowledge that the project was funded by the Lesbian Health Fund of the Gay and Lesbian Medical Association

the abstract of the grant will be publicized with the names of the Principal and Co-Investigator if the grant is funded

8. Evidence of the primary institution's tax exempt status

9. OPTIONAL: Articles or publications of direct relation to the proposed project.

Please number all pages and send 1 copy of each item as a email attachment to:

Amy Fielder, LHF Program Coordinator at lhf@glma.org

Questions? Email lhf@glma.org or call 202-600-8037 ext 303.

Pages